; Organ-on-a-Chip Market Size, Industry Share, Forecast, 2030

Organ-on-a-Chip Market

Organ-on-Chips Market By Type (liver, heart, lungs and others); By Application (drug discovery, toxicology research and other applications); By end-user (Pharmaceutical and biotechnology companies, academic and research institutes and others) and Region -Analysis of Market Size, Share and Trends for 2014 - 2019 and Forecasts to 2030.

Published on: Sep-2022
Report Code: FG HC 00027
No. of Pages: 170 - 350
Report Format: PDF

Product Overview

Organ-on-a-Chip Market to surpass USD 1271.6 million by 2031 from USD 68.3 million in 2021 at a CAGR of 38.50% in the forecasted period. 

Organ-on-chips is a glass slide coated with human cells configured to imitate a tissue such as a lung or heart. It is also called a multi-channel 3D microfluid cell culture chip which develops a narrow channel for blood and airflow in organs. It is an artificial organ that replicates the activities, mechanics, and physiological responses of the organ system. It is the size of a AA battery that allows seeing the functionality of organs, their behavior, and response at the molecular and cellular levels.

Market Highlights

Organ-on-a-Chip Market  is expected to project a CAGR of 38.50% during the forecast period, 2021-2031

An increase in animal testing, research funding, capital investments, new product launches, and a rise in technological investments is likely to increase the growth of the market.

Global Organ-on-Chips Market: Segments

By organ type

it can be categorized into the liver, heart, lungs, and others. The liver segment shows significant growth due to the increased liver-related diseases along with the ability of on-chip hepatic tissues to maintain metabolism.

By application

 it can be segmented into drug discovery, toxicology research, and other applications. Technological advancements and an increase in drug toxicity demand are reasons for the growth of the drug segment.

Market Dynamics

Drivers

High usage is expected to increase the market size

The growing usage of the organ-on-chips market for animal testing and in the healthcare sector and a rising number of alliances between the pharmaceutical firms and chips manufacturers are expected to increase the market growth. Additionally, technological advancements and an increase in drug toxicity demand is also a driver in the market.

Restraint

Technical issues and high costs will restrain the market growth

There are a lot of technical problems linked with organ-on-chip technology which acts as a restraint in the market along with the high cost as well as complexities in the organ-on-chip model. Restrictions in polydimethylsiloxane which is the most commonly used material for fabrications of the organ-on-chips market also act as a hindrance to the growth of the market.

Global Organ-on-Chips Market: Regions

North America holds the largest share in the organ-on-chips market due to the increased support of the government in drug discovery research activities as well as the presence of world-class research institutes and pharmaceutical and biotechnology industries in the region. Though, the APAC region is expected to become the fastest-growing region due to the increase in disposable income of the people and increased government funding for medicines in research institutes as well as the growing investments in research and development.

Global Organ-on-a-Chip Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities-o-Y Growth, CAGR – the United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and the Rest of APAC
  • MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Global Organ-on-Chips Market: Key players

  •  Nortis

Business Strategy, Key Product offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence,  SWOT Analysis

  • Organovo Holdings, Inc.
  • Hurel Corporation
  • Insphero AG
  • MIMETAS BV
  • Mimetas
  • Emulate
  • InSphero
  • Ascendance Bio
  • AxoSim

The global Organ-on-a-Chip Market report also contains an analysis on:

Global Organ-on-Chips Market segments

  • By type
    • Liver
    • Lungs
    • Heart
    • others
  • By application
    • drug discovery
    • toxicology research
    • other applications
  • By end-user
    • Pharmaceutical and biotechnology companies
    • academic and research institutes
    • others 
  • Global Organ-on-Chips Market dynamics
  • Global Organ-on-Chips Market size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

Frequently Asked Questions (FAQ):

The Organ-on-a-Chip Market size was estimated at USD 68.3 million in 2021 and is expected to reach USD 1271.6 million by 2030.

Nortis, Organovo Holdings, Inc., Hurel Corporation, Insphero AG, MIMETAS BV, Mimetas, Emulate, InSphero, Ascendance Bio, AxoSim

By organ type and By application segment are anticipated to hold the largest Food Service Equipment Market

Drivers: High usage is expected to increase the market size

Organ-on-chips is a glass slide coated with human cells configured to imitate a tissue such as a lung or heart. It is also called a multi-channel 3D microfluid cell culture chip which develops a narrow channel for blood and airflow in organs. It is an artificial organ that replicates the activities, mechanics, and physiological responses of the organ system.

Select License Type

$3199

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555



Select License Type

$3199

Report accessible by 1 user only

Sample Request

Client Testimonials

FATPOS CLIENT Appriciation DURING THE PROJECT

Clients